CBM - Cambrex Corporation

NYSE - Nasdaq Real Time Price. Currency in USD

Cambrex Corporation

One Meadowlands Plaza
East Rutherford, NJ 07073
United States

Full Time Employees1,732

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven M. KloskPres, CEO & Director2.21M9.76M1957
Mr. Gregory P. SargenExec. VP of Corp. Devel. & Strategy and CFO1.68M670.27k1966
Mr. Shawn P. CavanaghExec. VP & COO1.78M1.46M1966
Ms. Samantha M. HanleySr. VP, Gen. Counsel & Corp. Sec.918.25k780.41k1978
Ms. Alex MawDirector of Marketing & CommunicationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as finished dosage forms. The company serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

Corporate Governance

Cambrex Corporation’s ISS Governance QualityScore as of October 4, 2019 is 2. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 2; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.